Zymeworks, Inc. (ZYME)
23.32
-0.58
(-2.41%)
USD |
NASDAQ |
Mar 20, 16:00
23.50
+0.18
(+0.77%)
After-Hours: 20:00
Zymeworks EPS Diluted (Quarterly) : -0.547 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Royalty Pharma Plc | 0.4992 |
| Krystal Biotech, Inc. | 1.699 |
| Scholar Rock Holding Corp. | -0.8824 |
| Xeris Biopharma Holdings, Inc. | 0.0615 |
| Stoke Therapeutics, Inc. | -0.9922 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.21M |
| Revenue (Quarterly) | 2.515M |
| Total Expenses (Quarterly) | 43.72M |
| Enterprise Value | 1.522B |
| Gross Profit Margin (Quarterly) | 32.76% |
| Profit Margin (Quarterly) | -1.64K% |
| Earnings Yield | -4.63% |
| Normalized Earnings Yield | -4.614 |